Bookmark

Add to MyYahoo RSS

3SBio News

News on 3SBio (Ticker: SSRX) continually updated from thousands of sources around the net.

Jun 17, 2014 | Freshnews

Selecta Biosciences Enters Into Exclusive License Agreement with...

Selecta Biosciences Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune tolerance treatments, today announced it has entered into an exclusive license with 3SBio for pegsiticase , a pegylated recombinant uricase from candida utilis .

Comment?

Related Topix: Selecta Biosciences, Biotech, Medicine, Health, Gout

Sun Aug 11, 2013

Seeking Alpha

China Biotech In Review: Fundings For China-Affiliated Drug Companies

Shenogen Pharma of Beijing raised $20 million in a series C funding, which the company will use to support a Phase II trial of its lead drug candidate, icaritin, a small molecule drug that targets the estrogen receptor alpha 36. The trial will enroll patients with hepatocellular cancer.

Comment?

Related Topix: World News, China, Asia, Biotech, Science / Technology, Venture Capital, Emerging Technology, Stem Cell Research

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••